AOPEP and Cognitive impairment: Using the same PEA Olink assay as in the present study, HAGH was found to be increased in plasma from individuals with HIV-associated cognitive impairment [17], in amyloid β-positive individuals with mild cognitive impairment (MCI) and AD [39], and in APO E4-carrier individuals with AD [40].